Edwards Lifesciences Price to Book Ratio 2010-2023 | EW
Historical price to book ratio values for Edwards Lifesciences (EW) over the last 10 years. The current price to book ratio for Edwards Lifesciences as of March 28, 2024 is 8.59.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Edwards Lifesciences Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2024-03-28 | 95.56 | 8.55 | |
2023-12-31 | 76.25 | $11.18 | 6.82 |
2023-09-30 | 69.28 | $11.09 | 6.25 |
2023-06-30 | 94.33 | $10.60 | 8.90 |
2023-03-31 | 82.73 | $10.00 | 8.27 |
2022-12-31 | 74.61 | $9.55 | 7.82 |
2022-09-30 | 82.63 | $10.04 | 8.23 |
2022-06-30 | 95.09 | $9.59 | 9.92 |
2022-03-31 | 117.72 | $9.41 | 12.52 |
2021-12-31 | 129.55 | $9.35 | 13.85 |
2021-09-30 | 113.21 | $8.88 | 12.75 |
2021-06-30 | 103.57 | $8.24 | 12.57 |
2020-12-31 | 91.23 | $7.33 | 12.45 |
2020-09-30 | 79.82 | $6.76 | 11.81 |
2020-06-30 | 69.11 | $6.18 | 11.19 |
2020-03-31 | 62.87 | $6.30 | 9.98 |
2019-12-31 | 77.76 | $19.84 | 3.92 |
2021-03-31 | 83.64 | $7.49 | 11.16 |
2019-09-30 | 73.30 | $6.10 | 12.02 |
2019-06-30 | 61.58 | $5.61 | 10.97 |
2019-03-31 | 63.78 | $5.51 | 11.57 |
2018-12-31 | 51.06 | $5.04 | 10.13 |
2018-09-30 | 58.03 | $5.36 | 10.83 |
2018-06-30 | 48.52 | $5.04 | 9.62 |
2018-03-31 | 46.51 | $5.13 | 9.06 |
2017-12-31 | 37.57 | $4.70 | 8.00 |
2017-09-30 | 36.44 | $4.98 | 7.31 |
2017-06-30 | 39.41 | $4.64 | 8.49 |
2017-03-31 | 31.36 | $4.35 | 7.22 |
2016-12-31 | 31.23 | $4.13 | 7.57 |
2016-09-30 | 40.19 | $4.20 | 9.57 |
2016-06-30 | 33.24 | $3.87 | 8.58 |
2016-03-31 | 29.40 | $3.62 | 8.13 |
2015-12-31 | 26.33 | $3.87 | 6.80 |
2015-09-30 | 23.70 | $3.75 | 6.32 |
2015-06-30 | 23.74 | $3.55 | 6.68 |
2015-03-31 | 23.74 | $3.43 | 6.92 |
2014-12-31 | 21.23 | $6.78 | 3.13 |
2014-09-30 | 17.03 | $3.19 | 5.34 |
2014-06-30 | 14.31 | $3.01 | 4.75 |
2013-12-31 | 10.96 | $2.36 | 4.65 |
2013-09-30 | 11.61 | $2.19 | 5.30 |
2013-06-30 | 11.20 | $2.35 | 4.77 |
2013-03-31 | 13.69 | $2.34 | 5.86 |
2012-12-31 | 15.03 | $2.16 | 6.97 |
2014-03-31 | 12.36 | $2.12 | 5.82 |
2012-09-30 | 17.90 | $2.21 | 8.11 |
2012-06-30 | 17.22 | $2.07 | 8.30 |
2012-03-31 | 12.12 | $2.03 | 5.96 |
2011-12-31 | 11.78 | $1.95 | 6.03 |
2011-09-30 | 11.88 | $1.98 | 6.01 |
2011-06-30 | 14.53 | $2.01 | 7.23 |
2011-03-31 | 14.50 | $1.97 | 7.36 |
2010-12-31 | 13.47 | $1.90 | 7.11 |
2010-09-30 | 11.18 | $1.80 | 6.20 |
2010-06-30 | 9.34 | $1.65 | 5.67 |
2010-03-31 | 8.24 | $1.69 | 4.88 |
2009-12-31 | 7.24 | $3.40 | 2.13 |
2009-09-30 | 5.83 | $1.61 | 3.62 |
2009-06-30 | 5.67 | $1.48 | 3.83 |
2009-03-31 | 5.05 | $1.40 | 3.60 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $57.273B | $6.005B |
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $220.921B | 26.90 |
Intuitive Surgical (ISRG) | United States | $141.815B | 88.52 |
DexCom (DXCM) | United States | $53.772B | 92.37 |
IQVIA Holdings (IQV) | United States | $45.841B | 27.19 |
IDEXX Laboratories (IDXX) | United States | $44.833B | 53.58 |
Alcon (ALC) | Switzerland | $41.065B | 30.28 |
STERIS (STE) | Ireland | $22.285B | 26.38 |
Waters (WAT) | United States | $20.436B | 29.38 |
Hologic (HOLX) | United States | $18.156B | 20.04 |
SONOVA HOLDING (SONVY) | Switzerland | $17.399B | 0.00 |
ShockWave Medical (SWAV) | United States | $12.065B | 83.36 |
Sysmex ADR (SSMXY) | Japan | $11.407B | 35.78 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $11.361B | 14.03 |
Teleflex (TFX) | United States | $10.535B | 16.56 |
Penumbra (PEN) | United States | $8.762B | 108.32 |
Masimo (MASI) | United States | $7.645B | 42.87 |
Globus Medical (GMED) | United States | $7.183B | 22.77 |
Glaukos (GKOS) | United States | $4.585B | 0.00 |
Integer Holdings (ITGR) | United States | $3.844B | 24.64 |
LivaNova (LIVN) | United Kingdom | $3.015B | 19.88 |
Elekta AB (EKTAY) | Sweden | $2.904B | 19.92 |
Inari Medical (NARI) | United States | $2.747B | 474.00 |
Integra LifeSciences Holdings (IART) | United States | $2.738B | 11.23 |
PROCEPT BioRobotics (PRCT) | United States | $2.489B | 0.00 |
TransMedics (TMDX) | United States | $2.424B | 0.00 |
Nihon Kohden (NHNKY) | Japan | $2.388B | 20.19 |
Tandem Diabetes Care (TNDM) | United States | $2.317B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.904B | 0.00 |
RxSight (RXST) | United States | $1.874B | 0.00 |
Veracyte (VCYT) | United States | $1.586B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.997B | 0.00 |
Paragon 28 (FNA) | United States | $0.987B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.919B | 17.01 |
Artivion (AORT) | United States | $0.891B | 103.00 |
Treace Medical Concepts (TMCI) | United States | $0.763B | 0.00 |
OPKO Health (OPK) | United States | $0.746B | 0.00 |
Silk Road Medical (SILK) | United States | $0.733B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.682B | 0.00 |
SiBone (SIBN) | United States | $0.650B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.579B | 19.64 |
IRadimed (IRMD) | United States | $0.549B | 31.89 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.535B | 0.00 |
Nevro (NVRO) | United States | $0.525B | 0.00 |
Pulse Biosciences (PLSE) | United States | $0.463B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.377B | 12.69 |
CVRx (CVRX) | United States | $0.376B | 0.00 |
NeuroPace (NPCE) | United States | $0.358B | 0.00 |
AxoGen (AXGN) | United States | $0.336B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.262B | 0.00 |
Sight Sciences (SGHT) | United States | $0.257B | 0.00 |
Accuray (ARAY) | United States | $0.241B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.229B | 0.00 |
908 Devices (MASS) | United States | $0.229B | 0.00 |
AngioDynamics (ANGO) | United States | $0.227B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.206B | 0.00 |
Semler Scientific (SMLR) | United States | $0.201B | 10.81 |
Inogen (INGN) | United States | $0.186B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.181B | 0.00 |
Neuronetics (STIM) | United States | $0.143B | 0.00 |
Delcath Systems (DCTH) | United States | $0.125B | 0.00 |
Yubo Biotech (YBGJ) | China | $0.118B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.104B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
Envoy Medical (COCH) | United States | $0.076B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.073B | 0.00 |
Hyperfine (HYPR) | United States | $0.072B | 0.00 |
SEP Acquisition (SEPA) | United States | $0.071B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.064B | 130.67 |
Vasomedical (VASO) | United States | $0.057B | 4.36 |
InspireMD (NSPR) | Israel | $0.054B | 0.00 |
Autonomix Medical (AMIX) | $0.052B | 0.00 | |
Vicarious Surgical (RBOT) | United States | $0.051B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.048B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.048B | 0.00 |
ReWalk Robotics (LFWD) | Israel | $0.044B | 0.00 |
LENSAR (LNSR) | United States | $0.043B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.042B | 0.00 |
DarioHealth (DRIO) | United States | $0.041B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.035B | 0.00 |
Spectral AI (MDAI) | United States | $0.034B | 0.00 |
Precision Optics (POCI) | United States | $0.034B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
PAVmed (PAVM) | United States | $0.025B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.022B | 0.00 |
PetVivo Holdings (PETV) | United States | $0.018B | 0.00 |
Check-Cap (CHEK) | Israel | $0.016B | 0.00 |
NexGel (NXGL) | United States | $0.015B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.015B | 0.00 |
Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.009B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.009B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.007B | 0.00 |
Avinger (AVGR) | United States | $0.005B | 0.00 |
Venus Concept (VERO) | Canada | $0.004B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
Nuwellis (NUWE) | United States | $0.003B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
Tenon Medical (TNON) | United States | $0.002B | 0.00 |
Dynatronics (DYNT) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |